GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » Nutraceutical International Corp (NAS:NUTR) » Definitions » Cash Flow from Financing

Nutraceutical International (Nutraceutical International) Cash Flow from Financing : $1.2 Mil (TTM As of Jun. 2017)


View and export this data going back to 1998. Start your Free Trial

What is Nutraceutical International Cash Flow from Financing?

Cash from financing is the cash generated/spent from financial activities such as share issuance (buy back), debt issuance (repayment), and dividends paid to preferred and common stockholders.

For the three months ended in Jun. 2017, Nutraceutical International received $0.0 Mil more from issuing new shares than it paid to buy back shares. It received $14.0 Mil from issuing more debt. It paid $0.0 Mil more to buy back preferred shares than it received from issuing preferred shares. It received $0.0 Mil from paying cash dividends to shareholders. It spent $1.2 Mil on other financial activities. In all, Nutraceutical International earned $12.9 Mil on financial activities for the three months ended in Jun. 2017.


Nutraceutical International Cash Flow from Financing Historical Data

The historical data trend for Nutraceutical International's Cash Flow from Financing can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Nutraceutical International Cash Flow from Financing Chart

Nutraceutical International Annual Data
Trend Sep07 Sep08 Sep09 Sep10 Sep11 Sep12 Sep13 Sep14 Sep15 Sep16
Cash Flow from Financing
Get a 7-Day Free Trial Premium Member Only Premium Member Only -2.60 -11.55 5.70 -16.60 4.58

Nutraceutical International Quarterly Data
Sep12 Dec12 Mar13 Jun13 Sep13 Dec13 Mar14 Jun14 Sep14 Dec14 Mar15 Jun15 Sep15 Dec15 Mar16 Jun16 Sep16 Dec16 Mar17 Jun17
Cash Flow from Financing Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -4.34 -3.55 -3.98 -4.13 12.86

Nutraceutical International Cash Flow from Financing Calculation

This is the cash generated/spent from financial activities such as share issuance (buy back), debt issuance (repayment), and dividends paid to preferred and common stockholders. In the calculation of free cash flow, cash from financing is not calculated because it is not related to operating activities.

Nutraceutical International's Cash from Financing for the fiscal year that ended in Sep. 2016 is calculated as:

Nutraceutical International's Cash from Financing for the quarter that ended in Jun. 2017 is:


Cash Flow from Financing for the trailing twelve months (TTM) ended in Jun. 2017 adds up the quarterly data reported by the company within the most recent 12 months, which was $1.2 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Nutraceutical International  (NAS:NUTR) Cash Flow from Financing Explanation

Cash from financing contains six items:

1. Issuance of Stock:
A company may raise cash from issuing new shares. Issuance of stock represents the cash inflow from offering common stock, which is the additional capital contribution to the entity during the period.

Nutraceutical International's issuance of stock for the three months ended in Jun. 2017 was $0.0 Mil.

2. Repurchase of Stock:
A company may raise cash from issuing new shares. It can also use cash to buy back shares. Repurchase of stock represents the cash outflow to reacquire common stock during the period.

Nutraceutical International's repurchase of stock for the three months ended in Jun. 2017 was $0.0 Mil.

3. Net Issuance of Debt:
Net issuance of debt is the cash a company received or spent through debt related activities such as debt issuance or debt repayment. If a company pays down its debt during the period, this number will be negative. If a company issued more debt, it receives cash and this number is positive.

Nutraceutical International's net issuance of debt for the three months ended in Jun. 2017 was $14.0 Mil. Nutraceutical International received $14.0 Mil from issuing more debt.

4. Net Issuance of Preferred Stock:
A company may raise cash from issuing new preferred shares. It can also use cash to buy back preferred shares. If this number is positive, it means that the company has received more cash from issuing preferred shares than it has paid to buy back preferred shares. If this number is negative, it means that company has paid more cash to buy back preferred shares than it has received for issuing preferred shares.

Nutraceutical International's net issuance of preferred for the three months ended in Jun. 2017 was $0.0 Mil. Nutraceutical International paid $0.0 Mil more to buy back preferred shares than it received from issuing preferred shares.

5. Cash Flow for Dividends:
Cash flow for dividends refers to the payment of cash to shareholders as dividends when the company generates income.

Nutraceutical International's cash flow for dividends for the three months ended in Jun. 2017 was $0.0 Mil. Nutraceutical International received $0.0 Mil from paying cash dividends to shareholders.

6. Other Financing:
Money spent or earned by company from other financial activities.

Nutraceutical International's other financing for the three months ended in Jun. 2017 was $-1.2 Mil. Nutraceutical International spent $1.2 Mil on other financial activities.


Nutraceutical International Cash Flow from Financing Related Terms

Thank you for viewing the detailed overview of Nutraceutical International's Cash Flow from Financing provided by GuruFocus.com. Please click on the following links to see related term pages.


Nutraceutical International (Nutraceutical International) Business Description

Traded in Other Exchanges
N/A
Address
Nutraceutical International Corp was incorporated in Delaware in 1993. The Company is a manufacturer, marketer, distributor and retailer of branded nutritional supplements and other natural products sold to and through domestic health and natural food stores. Internationally, it markets and distributes branded nutritional supplements and other natural products to and through health and natural product distributors and retailers. Its core business is to acquire, integrate and operate businesses in the natural products industry that manufacture, market and distribute branded nutritional supplements. The Company manufactures and sells nutritional supplements and other natural products under numerous brands, including Solaray, KAL, Dynamic Health, Nature's Life, LifeTime, Natural Balance, NaturalCare, Health from the Sun, Pioneer, Nutra BioGenesis, Life-flo, Organix South, Heritage Store and Monarch Nutraceuticals. It owns neighborhood natural food markets, which operates under the trade names The Real Food Company, Thom's Natural Foods, Cornucopia Community Market and Granola's. It also owns health food stores, which operates under various trade names, including Fresh Vitamins and Peachtree Natural Foods. The Company's products includes vitamins and minerals, herbs, specialty formulas, personal care products, liquid nutritional products, homeopathics, functional foods and other products.
Executives
J Kimo Esplin director C/O NUTRACEUTICAL INTERNATIONAL CORP, 1400 KEARNS BLVD, PARK CITY UT 84060
Bain Capital Investors Llc 10 percent owner 200 CLARENDON STREET, BOSTON MA 02116
Bain Capital Fund Iv Lp 10 percent owner C/O BAIN CAPITAL LLC, TWO COPLEY PLACE, BOSTON MA 02199
Bcip Trust Associates Lp 10 percent owner C/O BAIN CAPITAL LLC, 111 HUNINGTON AVENUE, BOSTON MA 02199
Robert C Gay director C/O BAIN CAPITAL INC TWO COPLEY PLACE, BOSTON MA 02116
Matthew S Levin director BAIN CAPITAL PARTNERS LLC JOHN HANCOCK TOWER, 200 CLARENDON STREET BOSTON MA 02116
Associates Bcip 10 percent owner

Nutraceutical International (Nutraceutical International) Headlines